Two‐decade battle with myasthenia gravis: A breakthrough case report on the long‐term success with eculizumab and ravulizumab treatment
Key Clinical Message This unique case of generalized myasthenia gravis shows sustained stability of a patient's condition for 3 years with eculizumab/ravulizumab treatment following 16 years of refractory disease. It highlights the long‐term effectiveness of C5 inhibitors in a real‐world setting, ai...
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wiley
2024-11-01
|
| Serie: | Clinical Case Reports |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1002/ccr3.9547 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|